Phillips LK, Deane AM, Jones KL, Rayner CK, Horowitz M (2015) Gastric emptying and glycaemia in health and diabetes mellitus
This is because patients living with advanced malignant or non-malignant disease have a high risk of hospitalisation and/or death as a result of progression of their disease rather than due to the trial intervention or procedures
These drugs were developed to improve blood sugar control in patients with type 2 diabetes, but they also slow gastric emptying and reduce food intake, contributing to substantial weight loss in many users
Moreover, gene-environment interactions, often mediated by epigenetic modifications, may further modulate susceptibility to carcinogenic effects of NSW, complicating causal inference 11
Follow the ICD-10-CM Official Guidelines for Coding and Reporting